SCHEMBL192685

SCHEMBL192685

CC(C)(C)C1CC(=CO)C(=O)CCN1C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1621684 0.86 MAP1LC3B (0.30)
SCHEMBL409339 0.78 POLB (0.32)
SCHEMBL2866944 0.74 RIPK1 (0.30)
SCHEMBL7974123 0.71 CHRNA7 (0.33)
SCHEMBL7974127 0.71 CHRNA7 (0.33)
SCHEMBL2353287 0.71
SCHEMBL2353284 0.71
SCHEMBL3694503 0.69
SCHEMBL3692508 0.69
SCHEMBL4552113 0.69 OPRK1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120022046-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. 2012-01-26 US claimed
US-20120022046-A1 Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections SIGA TECHNOLOGIES, INC. 2012-01-26 US disclosed
EP-2400845-A1 THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS Siga Technologies, Inc. (US) 2012-01-04 EP disclosed